✦ LIBER ✦

Brain cancer prognosis: independent validation of a clinical bioinformatics approach

✍ Scribed by Raffaele Fronza; Michele Tramonti; William R Atchley; Christine Nardini

Book ID: 115027996
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 211 KB
Volume: 2
Category: Article
ISSN: 2043-9113
DOI: 10.1186/2043-9113-2-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical proteomics: Discovery of cancer

Clinical proteomics: Discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches—A prostate cancer perspective

✍ Balwir Matharoo-Ball; Graham Ball; Robert Rees 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 502 KB

Clinical significance of the nuclear rec

Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study

✍ Anieta M Sieuwerts; Marleen Ansems; Maxime P Look; Paul N Span; Vanja de Weerd; 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 507 KB

142 POSTER The role of the novel apoptos

142 POSTER The role of the novel apoptosis related gene BCL2L12 in prognosis and individualized treatment of breast cancer: a molecular and clinical approach

✍ H. Thomadaki; M. Talieri; A. Ardavanis; A. Scorilas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 132 KB

A panel of kallikrein markers can predic

A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

✍ Amine Benchikh; Caroline Savage; Angel Cronin; Gilles Salama; Arnauld Villers; H 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 252 KB

Linking epidermal growth factor plasma l

Linking epidermal growth factor plasma levels with the prognosis and treatment response of colorectal cancer patients treated with a minimally invasive approach: does it have clinical utility?

✍ John Spiliotis; Odysseas Zoras 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 110 KB

Analytical Validation of the Oncotype DX

Analytical Validation of the Oncotype DX Genomic Diagnostic Test for Recurrence Prognosis and Therapeutic Response Prediction in Node-Negative, Estrogen Receptor-Positive Breast Cancer

✍ Cronin, M.; Sangli, C.; Liu, M.-L.; Pho, M.; Dutta, D.; Nguyen, A.; Jeong, J.; W 📂 Article 📅 2007 🏛 American Association for Clinical Chemistry 🌐 English ⚖ 113 KB